Autor: |
Alberto Maria Marra, Leonardo Bencivenga, Roberta D'Assante, Giuseppe Rengo, Antonio Cittadini |
Přispěvatelé: |
Marra, Alberto Maria, Bencivenga, Leonardo, D'Assante, Roberta, Rengo, Giuseppe, Cittadini, Antonio |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
European Journal of Internal Medicine. 99:1-6 |
ISSN: |
0953-6205 |
DOI: |
10.1016/j.ejim.2022.01.019 |
Popis: |
Heart Failure with preserved Ejection Fraction (HFpEF) is nowadays considered a major healthcare issue. According to forecasts two third of all Heart Failure patients will belong to this phenotype by year 2050, overwhelming those affected by Heart Failure with reduced Ejection Fraction (HFrEF). Both epidemiological and mechanistic studies support the concept that HFpEF represents true HF although aggravated by a collection of comorbidities. There is urgent need of improving its phenotyping due to the high degree of disease heterogeneity within HFpEF that lead to the failure of randomized clinical trials in demonstrating a remarkable impact of drugs in improving its morbidity and mortality. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|